| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Cathepsin G-mediated proteolytic degradation of MHC class I molecules to facilitate immune detection of human glioblastoma cells
|
Palesch, David
|
|
2016
|
65 |
3 |
p. 283-291
|
artikel
|
| 2 |
Enhancement of tumor cell susceptibility to natural killer cell activity through inhibition of the PI3K signaling pathway
|
Bommarito, Davide
|
|
2016
|
65 |
3 |
p. 355-366
|
artikel
|
| 3 |
Exploiting IL-17-producing CD4+ and CD8+ T cells to improve cancer immunotherapy in the clinic
|
Majchrzak, Kinga
|
|
2016
|
65 |
3 |
p. 247-259
|
artikel
|
| 4 |
Identification of the murine H-2Db and human HLA-A*0201 MHC class I-restricted HPV6 E7-specific cytotoxic T lymphocyte epitopes
|
Peng, Shiwen
|
|
2016
|
65 |
3 |
p. 261-271
|
artikel
|
| 5 |
Immunoreceptor TIGIT inhibits the cytotoxicity of human cytokine-induced killer cells by interacting with CD155
|
Zhang, Baofu
|
|
2016
|
65 |
3 |
p. 305-314
|
artikel
|
| 6 |
Prophylactic vaccines are potent activators of monocyte-derived dendritic cells and drive effective anti-tumor responses in melanoma patients at the cost of toxicity
|
Bol, Kalijn F.
|
|
2016
|
65 |
3 |
p. 327-339
|
artikel
|
| 7 |
Requirement of interleukin 7 signaling for anti-tumor immune response under lymphopenic conditions in a murine lung carcinoma model
|
Suzuki, Toshihiro
|
|
2016
|
65 |
3 |
p. 341-354
|
artikel
|
| 8 |
TCR gene-modified T cells can efficiently treat established hepatitis C-associated hepatocellular carcinoma tumors
|
Spear, Timothy T.
|
|
2016
|
65 |
3 |
p. 293-304
|
artikel
|
| 9 |
TCR gene-modified T cells can efficiently treat established hepatitis C-associated hepatocellular carcinoma tumors
|
Spear, Timothy T.
|
|
|
65 |
3 |
p. 293-304
|
artikel
|
| 10 |
The fully synthetic MAG-Tn3 therapeutic vaccine containing the tetanus toxoid-derived TT830-844 universal epitope provides anti-tumor immunity
|
Laubreton, Daphné
|
|
2016
|
65 |
3 |
p. 315-325
|
artikel
|
| 11 |
The induction of human myeloid derived suppressor cells through hepatic stellate cells is dose-dependently inhibited by the tyrosine kinase inhibitors nilotinib, dasatinib and sorafenib, but not sunitinib
|
Heine, Annkristin
|
|
2016
|
65 |
3 |
p. 273-282
|
artikel
|
Tijdschrift beschrijving